Recent Advances in Porphyrin Metabolism

References

• Tschudy D. P. Biochemical lesions in porphyria. J.A.M.A. 1965; 191: 718
   PubMedGoogle Scholar
• Watson C. J., Taddeini L. The clinical porphyrias. Seminars Hemat. 1968; 5: 335
   PubMedGoogle Scholar
• Kappas A., Levere R. D., Granick S. The regulation of porphyrin and heme synthesis. Seminars Hemat. 1968; 5: 323
   PubMedGoogle Scholar
• Sano S., Granick S. Mitochondrial coproporphyrinogen oxidase and protoporphyrin formation. J. Biol. Chem. 1961; 236: 1173
   PubMed Web of Science ®Google Scholar
• Sardesai V. M., Waldman J., Orten J. M. A comparative study of porphyrin biosynthesis in different tissues. Blood 1964; 24: 178
   PubMedGoogle Scholar
• Granick S., Urata G. Increase in activity of a-aminolevulinic acid synthetase in liver mitochondria induced by feeding of 3, 5-dicarbethoxy, -1, 4-dihydrocollidine. J. Biol. Chem. 1963; 238: 821
   PubMed Web of Science ®Google Scholar
• Lascelles J. Tetrapyrrole Biosynthesis and its Regulation. W. A. Benjamin, Inc., New York 1966
   Google Scholar
• Granick S. The induction in vitro of the synthesis of δ-aminolevulinic acid synthetase in chemical porphyria: a response to certain drugs, sex hormones, and foreign chemicals. J. Biol. Chem. 1966; 241: 1359
   PubMed Web of Science ®Google Scholar
• McKay R., Druyan R., Getz G. S., Rabinowitz M. Intramitochondrial localization of δ-amino laevulate synthetase and ferrochelatase in rat liver. Biochem J. 1969; 114: 455
   PubMed Web of Science ®Google Scholar
• Jones M. S., Jones O. T. G. Evidence for the location of ferrochelatase on the inner membrane of rat liver mitochondria. Biochem. Biophys. Res. Comm. 1968; 31: 977
   PubMedGoogle Scholar
• Marver H. S., Tschudy D. P., Perlroth M. G., Collins A. δ-aminolevulinic acid synthetase. I. Studies in liver homogenates. J. Biol. Chem. 1966; 241: 2803
   PubMed Web of Science ®Google Scholar
• Hayashi N., Yoda B., Kikuchi G. Mechanism of allylisopropyl-acetamide-induced increase of δ-amino-levulinate synthetase in liver mitochondria IV. Accumulation of the enzyme in the soluble fraction of rat liver. Arch. Biochem. 1969; 131: 83
   PubMedGoogle Scholar
• Scholnick P. L., Hammaker L. E., Marver H. S. Soluble hepatic δ-aminolevulinic acid synthetase: end-product inhibition of the partially purified enzyme. Proc. Nat. Acad. Sci. 1969; 63: 65
   PubMedGoogle Scholar
• London I. M., Bruno G. P., Karibian D. The regulation of hemoglobin synthesis and the pathogenesis of some hypochromic anemias. Medicine 1964; 43: 789
   PubMedGoogle Scholar
• Karibian D., London I. M. Control of heme synthesis by feedback inhibition. Biochem. Biophys. Res. Comm. 1965; 18: 243
   PubMed Web of Science ®Google Scholar
• Welland F., Schwartz H. C. Effect of hemin on ALA synthetase. Clin. Res. 1966; 14: 142
   Google Scholar
• Bottomley S. S., Smithee J. A. Characterization and measurement of δ-aminolevulinate synthetase in bone marrow cell mitochondria. Biochim. Biophys. Acta. 1968; 159: 27
   PubMedGoogle Scholar
• Neuwirt J., Ponka P., Borová J. The role of heme in the regulation of δ-aminolevulinic acid and heme synthesis in rabbit reticulocytes. Europ. J. Biochem. 1969; 9: 36
   PubMedGoogle Scholar
• Marver H. S., Tschudy D. P., Perlroth M. G., Collins A. Coordinate synthesis of heme and apoenzyme in the formation of tryptophan pyrrolase. Science 1966; 154: 501
   PubMed Web of Science ®Google Scholar
• Feigelson P., Feigelson M., Greengard O. Comparison of the mechanisms of hormonal and substrate induction of rat liver tryptophan pyrrolase. Recent Progr. Hormone Res. 1962; 18: 491
   Google Scholar
• Onisawa J., Labbe R. F. Effects of diethyl-l, 4-dihydro-2, 4, 6, -trimethylpyridine-3, 5-dicarboxylate on the metabolism of porphyrins and iron. J. Biol. Chem. 1963; 238: 724
   PubMed Web of Science ®Google Scholar
• Wada O., Yano Y., Urata G., Nakao K. Behaviour of hepatic microsomal cytochromes after treatment of mice with drugs known to disturb porphyrin metabolism in liver. Biochem. Pharmacol. 1968; 17: 595
   PubMed Web of Science ®Google Scholar
• Creighton J. M., Marks G. P. Drug induced porphyrin biosynthesis I. The effect of porphyria inducing drugs on N-demethylase activity of chick embryo liver. Biochem. Pharmacol. 1969; 18: 2040
   PubMedGoogle Scholar
• Schmid R., Marver H. S., Hammaker L. Enhanced formation of rapidly labeled bilirubin by phenobarbital. Hepatic microsomal cytochrome as a possible source. Biochem. Biophys. Res Comm 1966; 24: 319
   PubMed Web of Science ®Google Scholar
• Robinson S. H., Tsong M., Brown B. W., Schmid R. The sources of bile pigment in the rat: Studies of the “early labeled” fraction. J. Clin. Invest. 1966; 45: 1569
   PubMed Web of Science ®Google Scholar
• Marver H. S. Experimental and acute intermittent porphyria: A suggested role of disordered drug metabolism. J. Lab. Clin. Med. 1966; 68: 996
   Google Scholar
• Meyer U. A., Marver H. S. Hepatic porphyria: inappropriate induction of delta aminolevulinic acid synthetase by enhanced hemoprotein turnover. J. Clin. Invest. 1970; 49: 66a
   Google Scholar
• Meyer U. A., Marver H. S. Chemically induced porphyria: Increased microsomal heme turnover after treatment with allylisopropyl-acetamide. Science 1971; 171: 64
   PubMed Web of Science ®Google Scholar
• Landaw S. A., Callahan E. W., Jr., Schmid R. Catabolism of heme in vivo: comparison of the simultaneous production of bilirubin and carbon monoxide. J. Clin. Invest. 1970; 49: 914
   PubMed Web of Science ®Google Scholar
• Sassa S., Granick S. Induction of δ-aminolevulinic acid synthetase in chick embryo liver cells in culture. Proc. Nat. Acad. Sci. 1970; 67: 517
   PubMed Web of Science ®Google Scholar
• Granick S., Levere R. D. Heme synthesis in erythroid cells. Progr. Hemat. 1964; 4: 1
   PubMedGoogle Scholar
• Watson C. J., Runge W., Taddeini L., Bossenmaier I., Cardinal R. A suggested control gene mechanism for the excessive production of types I and III porphyrins in congenital erythropoietic porphyria. Proc. Nat. Acad. Sci. 1964; 52: 487
   Google Scholar
• Tschudy D. P., Perlroth M. G., Marver H. S., Collins A., Hunter G. J., Rechail M. J. Acute intermittent porphyria: the first Overproduction Disease localized to a specific enzyme. Proc. Nat. Acad. Sci. 1965; 53: 841
   PubMed Web of Science ®Google Scholar
• Heilmeyer V. L., Clotten R. Die Storung der Porphyrinsynthese bei der Guntherschen Porphyria Congenita. Acta Haemat. 1965; 34: 65
   PubMedGoogle Scholar
• Romeo G., Levin E. Y. Uroporphyrinogen III cosynthetase in human congenital erythropoietic porphyria. Biochemistry 1969; 63: 856
   Google Scholar
• Masuya T. Pathophysiological observations on porphyrias. Acta Haemat. Jap. 1969; 32: 24
   Google Scholar
• Levin E. Y. Uroporphyrinogen III cosynthetase from mouse spleen. Biochemistry 1968; 7: 3781
   PubMedGoogle Scholar
• Levere R. D., Kappas A., personal communication
   Google Scholar
• Schwartz S., Johnson J. A., Stephenson B. D., Anderson A. S., Edmonson P. R., Fusaro R. M. Erythropoietic defects in protoporphyria: A reevaluation of early peak labeling. J. Lab. Clin. Med. 1970; 76: 893
   Google Scholar
• Porter F. S. Congenital erythropoietic protoporphyria II. An experimental study. Blood 1963; 22: 532
   PubMedGoogle Scholar
• Miyagi K. The liver ALA synthetase activity in erythropoietic protoporphyria by means of the new micromethod. J. Kyushi Hemat. Soc. 1967; 17: 397
   Google Scholar
• Scholnick P., Marver H. S., Schmid R. Erythropoietic protoporphyria: Evidence for multiple sites of excess protoporphyrin formation. J. Clin. Invest. 1971; 50: 203
   PubMed Web of Science ®Google Scholar
• Schwartz S., Johnson J. A., Stephenson B. D., Anderson A. S., Edmonson P. R., Fusaro R. M. Erythropoietic defects in protoporphyria; a study of factors involved in labelling of porphyrins and bile pigments from ALA-3H and Glyein-3 4C. J. Lab. Clin. Med., in press
   Google Scholar
• Strand L. J., Felsher B. F., Redeker A. G., Marver H. S. Intermittent acute porphyria (IAP). New evidence for a basic defect in uroporphyrinogen synthetase (UROS). J. Clin. Invest. 1971; 50: 89a
   Google Scholar
• Nakao K., Wada O., Kitamura T., Uono M. Activity of aminolaevulinic acid synthetase in normal and porphyric human livers. Nature 1966; 210: 838
   PubMedGoogle Scholar
• Dowdle E. B., Mustard P., Eales L. δ-aminolevulinic acid synthetase activity in normal and porphyric human livers. S. Afr. Med. J. 1967; 41: 1093
   PubMedGoogle Scholar
• Heilmeyer L., Clotten R. Zur biochemischen Pathogenese der Porphyria Acuta Intermittens. Klin. Wschr. 1969; 47: 71
   PubMedGoogle Scholar
• Sweeny V. P., Pathak M. A., Asbury A. K. Acute intermittent porphyria. Increased ALA synthetase activity during an acute attack. Brain 1970; 93: 369
   PubMedGoogle Scholar
• Strand L. J., Felsher B. F., Redeker A. G., Marver H. S. Heme biosynthesis in intermittent acute porphyria. Decreased hepatic conversion of porphobilinogen to porphyrins and increased delta aminolevulinic acid synthetase activity. Proc. Nat. Acad. Sci. 1970; 67: 1315
   PubMed Web of Science ®Google Scholar
• Miyagi K., Cardinal R., Bossenmaier J., Watson C. J. The serum porphobilinogen and the hepatic porphobilinogen deaminase in normal and porphyric individuals, in press
   Google Scholar
• Kaufman L., Marver H. S. Biochemical defects in two types of human hepatic porphyria. New Eng. J. Med. 1970; 283: 954
   PubMed Web of Science ®Google Scholar
• McLntyre N., Pearson A. J. G., Allan D. J., Craske S., West G. M. L., Moore M. R., Paxton J., Beattie A. D., Goldberg A. Hepatic δ-aminolaevulinic acid synthetase in an attack of hereditary coproporphyria and during remission. Lancet 1971; 1: 560
   PubMedGoogle Scholar
• Watson C. J. The problem of porphyria. Some facts and questions. New Eng. J. Med. 1960; 263: 1205
   PubMed Web of Science ®Google Scholar
• Zail S. S., Joubert S. M. Hepatic δ-aminolaevulinic acid synthetase activity in symptomatic porphyria. Brit. J. Haemat. 1968; 15: 123
   PubMedGoogle Scholar
• Shanley B. C., Zail S. S., Joubert S. M. Effect of ethanol on liver δ-aminolaevulinate synthetase activity and urinary porphyrin excretion in symptomatic porphyria. Brit. J. Haemat. 1969; 17: 389
   PubMedGoogle Scholar
• Levere R. D. Porphyrin synthesis in hepatic cirrhosis: Increase in δ-aminolevulinic acid synthetase. Biochem. Med. 1967; 1: 92
   Google Scholar
• Levere R. D. Stilbesterol induced porphyria: Increase in hepatic δ-aminolevulinic acid synthetase. Blood 1966; 28: 569
   PubMedGoogle Scholar
• Lottsfeldt F. I., Labbe R. F. Iron metabolism in experimental porphyria. Clin. Res. 1961; 9: 93
   Google Scholar
• Tschudy D. P. Acute intermittent porphyria. Seminars Hemat. 1968; 5: 370
   PubMedGoogle Scholar
• Magnus I. A. The cutaneous porphyrias. Seminars Hemat. 1968; 5: 380
   PubMedGoogle Scholar
• DeMatteis E. Toxic hepatic porphyrias. Seminars Hemat. 1968; 5: 409
   PubMedGoogle Scholar
• Hellman E. S., Tschudy D. P., Bartter F. C. Abnormal electrolyte and water metabolism in acute intermittent porphyria. Amer. J. Med. 1962; 32: 734
   PubMed Web of Science ®Google Scholar
• Nielsen B., Thorn N. A. Transient excess urinary excretion of antiduiretic material in acute intermittent porphyria with hyponatremia and hypomagnesemia. Amer. J. Med. 1965; 38: 345
   PubMedGoogle Scholar
• Perlroth M. G., Tschudy D. P., Marver H. S., Berard C. W., Zeigel R. F., Rechcigl M., Collins A. Acute intermittent porphyria. New morphologic and biochemical findings. Amer. J. Med. 1966; 41: 149
   PubMed Web of Science ®Google Scholar
• Ludwig G. D., Goldberg M. Hyponatremia in acute intermittent porphyria probably resulting from inappropriate secretion of antiduiretic hormone. Ann New York Acad. Sci. 1963; 104: 710
   PubMedGoogle Scholar
• Stein J. A., Tschudy D. P. Acute intermittent porphyria. A clinical and biochemical study of 46 patients. edicine 1970; 49: 1
   Google Scholar
• Tschudy D. P. Clinical aspects of drug reactions in hereditary hepatic porphyria. Ann N. Y. Acad. Sci 1968; 151: 850
   PubMedGoogle Scholar
• Henneman D. H., Bunker J. P. The pattern of intermediary carbohydrate metabolism in Cushing's syndrome. Amer. J. Med. 1957; 23: 34
   PubMedGoogle Scholar
• Wynn V., Doar J. W. H. Some effects of oral contraceptives on carbohydrate metabolism. Lancet 1966; 2: 715
   PubMed Web of Science ®Google Scholar
• Welland F. H., Hellman E. S., Gaddis E. M., Collins A., Hunter G. W., Jr., Tschudy D. P. Factors affecting the excretion of porphyrin precursors by patients with acute intermittent porphyria. I The effect of diet. Metabolism 1964; 13: 232
   PubMed Web of Science ®Google Scholar
• Perlroth M. G., Tschudy D. P., Ratner A., Spaur W., Redeker A. The effect of diet in Variegate (South African) Porphyria. Metabolism 1968; 17: 571
   PubMedGoogle Scholar
• Redeker A. D., Sterling R. E. The “glucose effect” in erythropoietic protoporphyria. Arch. Intern. Med. 1968; 121: 446
   PubMedGoogle Scholar
• Rose J. A., Hellman E. S., Tschudy D. P. Effect of diet on induction of experimental porphyria. Metabolism 1961; 10: 514
   PubMed Web of Science ®Google Scholar
• Tschudy D. P., Welland F. H., Collins A., Hunter G. The effect of carbohydrate feeding on the induction of δ-aminolevulinic acid synthetase. Metabolism 1964; 13: 396
   PubMedGoogle Scholar
• Zimmerman T. S., McMillin J. M., Watson C. J. Onset of manifestations of hepatic porphyria in relation to the influence of female sex hormones. Arch. Inter. Med. 1966; 118: 229
   PubMedGoogle Scholar
• Granick S., Kappas A. Steroid control of porphyrin and heme biosynthesis: A new biological function of steroid hormone metabolites. Proc. Nat. Acad. Sci 1967; 57: 1463
   PubMedGoogle Scholar
• Kappas A., Granick S. Experimental hepatic porphyria: Studies with steroids of physiologic origin in man. Ann N. Y. Acad Sci 1968; 151: 842
   PubMedGoogle Scholar
• Goldberg A., Moore M. R., Beattie A. D., Hall P. E., McCallum J., Grant J. K. Excessive urinary excretion of certain porphyrinogenic steroids in human acute intermittent porphyria. Lancet 1969; 1: 115
   PubMedGoogle Scholar
• Kappas A., Song C. S., Sassa S., Levere R. D., Granick S. The occurrence of substances in human plasma capable of inducing the enzyme δ-aminolevulinate synthetase in liver cells. Proc. Nat. Acad. Sci. 1969; 64: 557
   PubMedGoogle Scholar
• Hollander C. S., Scott R. L., Tschudy D. P., Perlroth M., Waxman A., Sterling K. Increased protein-bound iodine and thyroxine-binding globulin in acute intermittent porphyria. New Eng J. Med. 1967; 277: 995
   PubMedGoogle Scholar
• Taddeini L., Nordstrom K. L., Watson C. J. Hypercholesterolemia in experimental and human hepatic porphyria. Metabolism 1964; 13: 691
   PubMedGoogle Scholar
• Lees R. S., Song C. S., Levere R. D., Kappas A. Hyperbeta-lipoproteinemia in acute intermittent porphyria. New Eng. J. Med. 1970; 282: 432
   PubMedGoogle Scholar
• Kappas A., Song C. S., Sachson R. A., Levere R. D., Granick S. The induction of δ-aminolevulinic acid synthetase in vivo in chick embryo liver by natural steroids. Proc. Nat. Acad. Sci 1968; 61: 509
   PubMedGoogle Scholar
• Levere R. D., Granick S. Control of hemoglobin synthesis in the cultured chick blastoderm. J. Biol. Chem. 1967; 242: 1903
   PubMedGoogle Scholar
• Levere R. D., Kappas A., Granick S. Stimulation of hemoglobin synthesis in chick blastoderm by certain 5β androstane and 5β pregnane steroids. Proc. Nat. Acad. Sci. 1967; 58: 985
   PubMedGoogle Scholar
• Gordon A. S., Zanjani E. D., Levere R. D., Kappas A. Stimulation of mammalian erythropoiesis by 5β-H steroid metabolites. Proc. Nat. Acad. Sci. 1970; 65: 919
   PubMedGoogle Scholar
• Gorsheim D., Gardner F. H. Erythropoietic activity of steroid metabolites in mice. Proc. Nat. Acad. Sci. 1970; 65: 564
   PubMedGoogle Scholar
• Mizoguchi H., Levere R. D. Enhancement of heme and globin synthesis in cultured human marrow by certain 5β-H steroid metabolites. J. Exp. Med. December, 1971, in press
   PubMedGoogle Scholar
• Kappas A., Bradlow H. L., Gillette P. M., Gallagher T. F. Abnormal steroid hormone metabolism in the genetic liver disease with intermittent porphyria. Proc. Nat. Acad. Sci. 1971; 179: 611
   Google Scholar